Related Experiment Videos
Muscular weakness in systemic lupus erythematosus
R Omdal1, S I Mellgren, O A Henriksen
1Department of Rheumatology, University Hospital of Tromso, Norway.
The Journal of Rheumatology
|September 1, 1991
Summary
Systemic lupus erythematosus (SLE) patients show muscular weakness linked to nerve and muscle issues. Weakness signs correlate with fatigue, disease activity, anemia, and inflammation, highlighting varied impacts.
Area of Science:
- Neurology
- Rheumatology
- Systemic Lupus Erythematosus (SLE) research
Background:
- Muscular weakness is a potential complication in Systemic Lupus Erythematosus (SLE).
- Standardized assessment of neurological involvement in SLE patients is crucial for understanding disease impact.
- Previous studies may not have systematically correlated specific clinical and laboratory findings with muscular weakness in SLE.
Purpose of the Study:
- To systematically evaluate the characteristics and correlates of muscular weakness in patients with Systemic Lupus Erythematosus (SLE).
- To differentiate the factors associated with symptoms versus signs of muscular weakness in SLE.
- To establish a baseline for understanding the significance and prevalence of muscular weakness in SLE.
Main Methods:
- Utilized standardized neurological scoring systems: Neuropathy Symptom Score for symptoms and Neurological Disability Score for signs.
- Systematically assessed a series of patients diagnosed with Systemic Lupus Erythematosus (SLE).
- Performed statistical analyses to identify associations between weakness measures and various clinical, laboratory, and disease activity parameters.
Main Results:
- Muscular weakness symptoms in SLE patients were statistically linked to clinical and electrophysiological evidence of nerve and muscle disease.
- Muscular weakness signs in SLE patients showed statistical associations with malaise, disease activity, anemia, age, and elevated erythrocyte sedimentation rate.
- Different variables influencing SLE disease were found to differentially affect the symptoms and signs of muscular weakness.
Conclusions:
- Muscular weakness in SLE is multifactorial, with distinct associations for symptoms and signs.
- Understanding these varied associations is essential for accurate diagnosis and management of neurological complications in SLE.
- Further research is needed to establish the precise significance and prevalence of muscular weakness in the broader SLE population.